September 29th is World Heart Day. This year the World Heart Federation's global campaign is called "Don't Miss a Beat" — a title that could apply just as easily to how most of us treat our own hearts as it does to the condition itself. Ask most women what they're most worried about health-wise, and the answer is rarely their heart. Breast cancer, usually. Sometimes menopause symptoms, sometimes mental health. Heart disease barely registers.
Here's the uncomfortable fact: it should be at the very top of the list. Cardiovascular disease is the leading cause of death in women — not breast cancer, not any other single condition. So why isn't it treated that way? The evidence points to some genuinely surprising, and genuinely fixable, reasons.
The scale of it
A 2021 report from a Lancet Commission dedicated entirely to women and cardiovascular disease — authored by 17 experts across 11 countries — put hard numbers on what had long been suspected. In 2019 alone, an estimated 275 million women worldwide were living with cardiovascular disease, which accounted for 35% of all female deaths globally. Heart attacks caused nearly half of those deaths; stroke caused over a third.
The Commission's chair, Professor Roxana Mehran, summed up the core problem in a single sentence: cardiovascular disease in women remains "understudied, under-recognised, under-diagnosed, and under-treated globally." Four separate failures, all compounding each other. Women have been significantly under-represented in the clinical trials that shape how heart disease is understood and treated, and risk factors specific to women — early menopause, pregnancy complications — still aren't widely recognised, even by clinicians.
Why don't we prioritise it? The awareness gap is getting worse, not better
This is the part that should stop us in our tracks. A major American Heart Association survey, published in the journal Circulation, tracked women's awareness that heart disease is their leading cause of death over a ten-year period. In 2009, 64.8% of women knew this. By 2019, that figure had fallen to just 43.7% — awareness went backwards, not forwards. The decline was worst among Black, Hispanic and Asian women, and — perhaps most tellingly — worst among women aged 25 to 34, the group with the most time to act on that knowledge.
Part of the explanation sits with the healthcare system itself, not just public awareness. A 2024 consensus document published in Heart (the BMJ Group's cardiology journal), produced jointly by British cardiovascular societies, found that women receive lower rates of diagnosis and treatment across every category of cardiovascular disease, and that even well-established risk factors like high blood pressure and high cholesterol are treated less promptly and less aggressively in women than in men. The authors pointed to "myths and unconscious biases within clinical practices" as part of the problem — despite stating plainly that cardiovascular disease "does not discriminate by sex."
And symptoms themselves play a role. Harvard Health notes that women are more likely to develop a form of heart failure where the heart contracts normally but the ventricles stiffen — a pattern that can look and feel different from the "textbook" heart failure more commonly described in men, and can be missed or dismissed as a result. The same article notes a striking risk difference: women with diabetes carry five times the heart failure risk of women without it, compared with a two-fold increase in men with diabetes — a gap that's still not widely known, even among women managing diabetes themselves.
The menopause connection
This is where the story becomes especially relevant to the women we work with every day.
A 2020 scientific statement from the American Heart Association, published in Circulation, identified the menopause transition itself as a distinct turning point for cardiovascular risk — not simply a marker of getting older. During this window, cholesterol rises, fat shifts toward the abdomen, blood pressure climbs and blood sugar regulation worsens, often in the space of just a few years. The statement's authors called midlife "a critical window" for early intervention, specifically because so many risk factors move in the wrong direction simultaneously.
Timing matters even more for women who go through menopause early. A 2026 study in JAMA Cardiology, following over 10,000 postmenopausal Black and white women across six decades of US health data, found that women who experienced menopause before age 40 carried roughly a 40% higher lifetime risk of coronary heart disease than women who reached menopause later. Lead author Dr Priya Freaney explained the mechanism plainly: "As estrogen declines, cholesterol and blood pressure go up, body fat shifts to the abdomen, muscle mass decreases, blood sugars dysregulate and arteries stiffen." The same study found premature menopause occurs three times more often in Black women than white women — a disparity with real consequences for cardiovascular equity.
Pregnancy offers an even earlier warning sign than most people realise. A 2023 Swedish case-control study published in BJOG, comparing over 2,600 women who went on to have a cardiovascular event with more than 13,000 matched women who didn't, found that a history of pre-eclampsia nearly tripled future cardiovascular risk, and gestational diabetes raised it by around 50% — both independent of a woman's weight. In other words, pregnancy can act as an early stress test for the cardiovascular system, one that too often goes unmentioned again until decades later.
What this means for now, and for later
Put these findings together and a pattern emerges: heart health in women isn't a single-life-stage issue, and it doesn't announce itself the way we've been taught to expect. It builds quietly, it shifts hardest during hormonal transitions, and it's easiest to influence early — long before a crisis makes it impossible to ignore.
That's exactly why this belongs in the same conversation as everything else we talk about: know your numbers (blood pressure, cholesterol, blood sugar) the way you'd know any other vital statistic about yourself. If you had pre-eclampsia or gestational diabetes, mention it to your GP as part of your cardiovascular history, not just your pregnancy history. If you're approaching perimenopause or menopause, ask about heart health specifically, not only hot flushes and mood. And if something feels different in your body — breathlessness, unusual fatigue, symptoms that don't match what you've been told a "heart attack" is supposed to feel like — don't talk yourself out of getting it checked.
This is longevity work, not just symptom management. The evidence is clear that the biggest wins come from acting during the windows when change is happening fastest — which, for many of us, means right now.
If you'd like support navigating hormone health and midlife wellbeing more broadly, The Balance Project runs clinician-led workshops and community days throughout the year — find out more at thebalanceproject.ie/events.
Always with balance. Always with you.
Blog by Georgie Sliney McCormack & Helen Flynn
Georgie and Helen are the co-founders of The Balance Project. Through their work, they are committed to making women's health information more accessible, informed, and empowering. They believe better conversations lead to better understanding, better support, and better outcomes for women.